logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Adrian Towse

AstraZeneca

39H指数
292论文数
5.4K被引数
收录论文 49
发表时间
logo
Pricing combination products: not how but who?定价组合产品：不是方法问题，而是主体问题？
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2025-04-17
err0
errOAAI
errTowse, Adrian; Briggs, Andrew; Steuten, Lotte
err分享
err收藏
Proposal for a General Outcome-Based Value Attribution Framework for Combination Therapies联合治疗的基于结果的一般价值归因框架的建议
errVALUE IN HEALTH
IF6
err2025-01-01
err0
PREAI
errSteuten, Lotte; Lothgren, Mickael; Bruce, Andrew; Campioni, Marco; Towse, Adrian
err分享
err收藏
The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom
errVALUE IN HEALTH
IF6
err2023-03-01
err3
PREAI
errBerdud, Mikel; Wallin-Bernhardsson, Niklas; Zamora, Bernarda; Lindgren, Peter; Towse, Adrian
err分享
err收藏
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study
errVACCINES
IF3.4
err2023-01-20
err5
errOAAI
errDi Fusco, Manuela; Mendes, Diana; Steuten, Lotte; Bloom, David E.; Drummond, Michael; Hauck, Katharina; Pearson-Stuttard, Jonathan; Power, Rachel; Salisbury, David; Towse, Adrian; Roiz, Julie; Szabo, Gabor; Yang, Jingyan; Marczell, Kinga
err分享
err收藏
Why We Need a New Outcomes-Based Value Attribution Framework for Combination Regimens in Oncology为什么我们需要一个新的基于结果的价值归因框架用于肿瘤学的联合治疗
errVALUE IN HEALTH
IF6
err2022-11-01
err4
PREAI
errTowse, Adrian; Lothgren, Mickael; Steuten, Lotte; Bruce, Andrew
err分享
err收藏
Considering Severity in Health Technology Assessment: Can We Do Better?考虑卫生技术评估的严重性: 我们能做得更好吗？
errVALUE IN HEALTH
IF6
err2022-08-01
err20
errOAAI
errSkedgel, Chris; Henderson, Nadine; Towse, Adrian; Mott, David; Green, Colin
err分享
err收藏
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2022-06-07
err14
errOAAI
errSampson, Chris; Zamora, Bernarda; Watson, Sam; Cairns, John; Chalkidou, Kalipso; Cubi-Molla, Patricia; Devlin, Nancy; Garcia-Lorenzo, Borja; Hughes, Dyfrig A.; Leech, Ashley A.; Towse, Adrian
err分享
err收藏
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations
errVALUE IN HEALTH
IF6
err2021-11-01
err14
errOAAI
errGarrison, Louis P.; Pezalla, Ed; Towse, Adrian; Yang, Hongbo; Faust, Elizabeth; Wu, Eric Q.; Li, Nanxin; Sawyer, Eileen K.; Recht, Michael
err分享
err收藏
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
errVALUE IN HEALTH
IF6
err2021-05-01
err9
errOAAI
errTowse, Adrian; Chalkidou, Kalipso; Firth, Isobel; Kettler, Hannah; Silverman, Rachel
err分享
err收藏
Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.
errMEDICAL DECISION MAKING
IF2.3
err2021-02-25
err2
errOAAI
errSampson, Chris; Firth, Isobel; Towse, Adrian
err分享
err收藏
Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB
errBMJ GLOBAL HEALTH
IF6.1
err2020-04-23
err3
errOAAI
errChalkidou, Kalipso; Towse, Adrian; Silverman, Rachel; Garau, Martina; Ramakrishnan, Ganesh
err分享
err收藏
Economic evaluation of meningococcal vaccines: considerations for the future
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2019-11-21
err28
errOAAI
errChristensen, Hannah; Al-Janabi, Hareth; Levy, Pierre; Postma, Maarten J.; Bloom, David E.; Landa, Paolo; Damm, Oliver; Salisbury, David M.; Diez-Domingo, Javier; Towse, Adrian K.; Lorgelly, Paula K.; Shah, Koonal K.; Hernandez-Villafuerte, Karla; Smith, Vinny; Glennie, Linda; Wright, Claire; York, Laura; Farkouh, Raymond
err分享
err收藏
Specific Value Assessment Considerations
errVALUE IN HEALTH
IF6
err2019-06-01
err4
errOAAI
errKamal-Bahl, Sachin; Towse, Adrian; Spurgin, Liz; Danzon, Patricia M.
err分享
err收藏
ALIGNING VALUE IN REGULATORY REVIEW, PRACTICE PATHWAYS, AND HEALTH TECHNOLOGY ASSESSMENT
errVALUE IN HEALTH
IF6
err2019-05-01
err0
errOAAI
errGarrison, L.; Towse, A.
err分享
err收藏
Is rate of return pricing a useful approach when value-based pricing is not appropriate?
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2019-02-15
err17
errOAAI
errDrummond, Michael; Towse, Adrian
err分享
err收藏
SHOULD DRUG PRICES DIFFER BY INDICATION? OUTLINING THE DEBATE ON INDICATION-BASED PRICING AND HOW IT HAS BEEN IMPLEMENTED
errVALUE IN HEALTH
IF6
err2018-10-01
err0
errOAAI
errChapman, A.; Zamora, B.; Towse, A.
err分享
err收藏
ESTABLISHING AN ALIGNED VIEW OF MODERN, FORWARD-LOOKING HTA PROCESS
errVALUE IN HEALTH
IF6
err2018-10-01
err0
errOAAI
errNeri, M.; Hampson, G.; Towse, A.
err分享
err收藏
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2018-09-18
err90
errOAAI
errJonsson, Bengt; Hampson, Grace; Michaels, Jonathan; Towse, Adrian; von der Schulenburg, J. -Matthias Graf; Wong, Olivier
err分享
err收藏
Paying for Cures: Perspectives on Solutions to the Affordability Issue
errVALUE IN HEALTH
IF6
err2018-03-01
err27
errOAAI
errSchaffer, Sarah Karlsberg; Messner, Donna; Mestre-Ferrandiz, Jorge; Tambor, Ellen; Towse, Adrian
err分享
err收藏
Affordability of New Technologies: The Next Frontier
errVALUE IN HEALTH
IF6
err2018-03-01
err20
errOAAI
errTowse, Adrian; Mauskopf, Josephine A.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Milton C. Weinstein
H 指数: 110 · 论文数: 631
J
John Rex
H 指数: 101 · 论文数: 544
A
Andrew Briggs
H 指数: 101 · 论文数: 808
M
Mark V. Pauly
H 指数: 98 · 论文数: 744
M
Mark Sculpher
H 指数: 94 · 论文数: 645
查看更多